Excluded, not dismissed: Enhancing benefit in clinical research

被引:1
作者
Nardell, Maria [1 ]
Chhabra, Akansha [2 ]
Pal, Lubna [3 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06510 USA
[2] NYU, Sch Med, New York, NY USA
[3] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA
基金
美国国家卫生研究院;
关键词
Ethics; Clinical research; Eligibility criteria; POLYCYSTIC-OVARY-SYNDROME; ANCILLARY-CARE; PARTICIPATION; KNOWLEDGE;
D O I
10.1016/j.cct.2012.08.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Participation in clinical research projects may allow an opportunity for early detection of covert diseases and subclinical disorders in asymptomatic volunteers from study-specific screening process. Exclusion of a potential participant due to failure to meet inclusion criteria eliminates any possibility of potential for research related benefit, as may exist for those that are deemed eligible and allowed to proceed with participation in the specific research study. Although the institutional bodies overseeing conduct of clinical research strive to ensure an ongoing scrutiny and prioritization of participants' wellbeing, we perceive that these mechanisms fall short as regards the interests of those volunteers who are subsequently excluded from participation in clinical research of relevance. While provision of ancillary care to address health concerns that are unmasked during the screening process may be an optimal strategy, the likelihood of successfully implementing this latter concept in current times of fiscal constraints is slim to nonexistent. Through this submission, we hope to initiate a dialogue within the research community regarding whether the current paradigm of conduct of clinical research be modified to include some degree of consideration for the screened out. We herein propose that for those volunteering for disease/disorder specific clinical research, some added degree of benefit can be assured to the screened out population through the provision of targeted health education or counseling. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:70 / 73
页数:4
相关论文
共 14 条
[1]  
Alm-Roijer Carin, 2006, J Cardiovasc Nurs, V21, pE24
[2]   Clinical ethics versus clinical research [J].
Appelbaum, Paul S. ;
Lidz, Charles W. .
AMERICAN JOURNAL OF BIOETHICS, 2006, 6 (04) :53-55
[3]   Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span [J].
Azziz, R ;
Marin, C ;
Hoq, L ;
Badamgarav, E ;
Song, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4650-4658
[4]  
Barlow JH, 1998, BRIT J RHEUMATOL, V37, P373
[5]   Women's Perceptions of Polycystic Ovary Syndrome Following Participation in a Clinical Research Study: Implications for Knowledge, Feelings, and Daily Health Practices [J].
Colwell, Katie ;
Lujan, Marla E. ;
Lawson, Karen L. ;
Pierson, Roger A. ;
Chizen, Donna R. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2010, 32 (05) :453-459
[6]   Factors influencing enrollment in clinical trials for cancer treatment [J].
Klabunde, CN ;
Springer, BC ;
Butler, B ;
White, MS ;
Atkins, J .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (12) :1189-1193
[7]  
Larsen Jennifer, 2011, Seminars in Speech and Language, V32, P338, DOI 10.1055/s-0031-1292759
[8]   The limitations of "vulnerability" as a protection for human research participants [J].
Levine, C ;
Faclen, R ;
Grady, C ;
Hammerschmidt, D ;
Eckenwiler, L ;
Sugarman, J .
AMERICAN JOURNAL OF BIOETHICS, 2004, 4 (03) :44-49
[9]  
Miller FG, 1998, JAMA-J AM MED ASSOC, V280, P149
[10]  
Pal L, 2012, GYNECOL ENDOCRINOL